logo
Select company
Select metric
-2008.02%EBITDA Margin
VS
Market
4
Sector
14
Industry
4
History
-
$ 5.35Close
$ 3.04 - $ 25.83 52-Week Range
Ticker Information

Ticker

BIOA

Company Name

BIOAGE LABS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

BIOAGE LABS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BIOA - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -77.57M-2008.02%$ 3.86M
12/31/2024$ -68.57M0%$ 0
12/31/2023$ -55.9M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOAGE LABS INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, BIOAGE LABS INC's average EBITDA % has been -2008.02%.
  • The median EBITDA % for BIOAGE LABS INC during this period was -2008.02%
  • BIOAGE LABS INC reached its highest EBITDA % over the past 5 years at -2008.02%.
  • The lowest EBITDA % recorded by BIOAGE LABS INC in the same timeframe -2008.02%

BIOAGE LABS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
OBIO : ORCHESTRA BIOMED HOLDINGS INC -2330.57%SCYX : SCYNEXIS INC -592.14%ACOG : ALPHA COGNITION INC -433.13%LUCD : LUCID DIAGNOSTICS INC -1246.7%CPHI : CHINA PHARMA HOLDINGS INC -39.62%ARMP : ARMATA PHARMACEUTICALS INC -253.28%IXHL : INCANNEX HEALTHCARE INC -53879.07%AVR : ANTERIS TECHNOLOGIES GLOBAL CORP -CTOR : CITIUS ONCOLOGY INC -IMDX : INSIGHT MOLECULAR DIAGNOSTICS INC -1441.13%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for BIOAGE LABS INC is calculated as follows: EBITDA [ $ -55.9M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

BIOA - EBITDA Margin, Last 5 years

-2008.02%

Minimum

Jun 30, 2025

-2008.02%

Maximum

Jun 30, 2025

-2008.02%

Average

-2008.02%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%